Personalizing the future of mental health and addiction.
Pure’s new approach is data-driven and allows AI to look at the ‘whole human’ profile across genetic, medical and mental health, and leverage this to match each client to the right safe supply and therapy plan with the highest statistical probability of outcome success.
We are looking to advance our work on this platform with an ecosystem of partners including insurers, physicians and pharmacists, who understand the need to not only implement a complete set of safe supply compounds but also pair that with the right data-driven therapeutic approaches.